Tiopronin
NDC 44523-054, Tiopronin, tablet, delayed release, from BioComp Pharma, Inc..
- Product NDC
- 44523-054
- Status
- Listed
- Labeler
- BioComp Pharma, Inc.
- Dosage form
- TABLET, DELAYED RELEASE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA AUTHORIZED GENERIC
- Application
- NDA211843
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/44523-054 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- TIOPRONIN100 mg/1
Pharmacologic classes
Cystine Disulfide Reduction [MoA]; N-substituted Glycines [CS]; Reducing and Complexing Thiol [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 44523-054-01 | 44523005401 | 300 TABLET, DELAYED RELEASE in 1 BOTTLE (44523-054-01) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/1f2eb1d6-faa6-e352-e063-6294a90a7fb5
Use it
Look up 44523-054 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/44523-054 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 44523-054. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.